Share on StockTwits

Egalet Corp (NASDAQ:EGLT) Insider Mark Strobeck sold 5,700 shares of Egalet Corp stock on the open market in a transaction that occurred on Monday, August 11th. The stock was sold at an average price of $10.28, for a total transaction of $58,596.00. Following the completion of the transaction, the insider now directly owns 130,415 shares of the company’s stock, valued at approximately $1,340,666. The sale was disclosed in a filing with the SEC, which is available at this link.

Egalet Corp (NASDAQ:EGLT) traded down 11.32% during mid-day trading on Tuesday, hitting $9.01. 27,617 shares of the company’s stock traded hands. Egalet Corp has a 52-week low of $9.54 and a 52-week high of $19.85. The stock’s 50-day moving average is $12.42 and its 200-day moving average is $13.01. The company’s market cap is $143.1 million.

Egalet Corp (NASDAQ:EGLT) last issued its quarterly earnings data on Tuesday, August 12th. The company reported ($0.73) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.42) by $0.31. On average, analysts predict that Egalet Corp will post $-2.67 earnings per share for the current fiscal year.

Egalet Corporation is a specialty pharmaceutical company developing and focuses on commercializing, abuse-deterrent oral products for the treatment of pain and in other indications.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.